News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mirabelli Christopher
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Mirabelli Christopher (Chairman of the Board) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 70,000 options to buy
@ $2.21, valued at
$154.7k
|
|
| 04/04/2023 |
4
| Mirabelli Christopher (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 500,000 options to buy
@ $0.34, valued at
$170k
|
|
| 09/02/2022 |
4
| Mirabelli Christopher (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 200,000 options to buy
@ $1.43, valued at
$286k
|
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Mirabelli Christopher (10% Owner) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 30,000 options to buy
@ $1.62, valued at
$48.6k
|
|
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| Mirabelli Christopher (10% Owner) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 150,000 options to buy
@ $2.57, valued at
$385.5k
Granted 50,000 restricted stock units
@ $0 |
|
| 08/12/2020 |
4
| Mirabelli Christopher (Chairman of the Board) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 75,000 options to buy
@ $1.97, valued at
$147.8k
|
|
| 04/13/2020 |
4
| Mirabelli Christopher (10% Owner) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $1.69, valued at
$84.5k
|
|
| 06/12/2019 |
4
| Mirabelli Christopher (Pres., CEO & Chairman of Board) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 200,000 options to buy
@ $1.39, valued at
$278k
|
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Mirabelli Christopher (Pres,CEO Chairman of Board) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $2, valued at
$100k
|
|
| 08/01/2018 |
4
| Mirabelli Christopher (CEO, President and COB) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Acquired 21,369 warrants
@ $6.085, valued at
$130k
|
|
| 04/20/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2017 |
4
| Mirabelli Christopher (CEO, President, COB) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Bought 1,057,769 shares
@ $6.085, valued at
$6.4M
Bought 1,057,769 warrants
@ $6.085, valued at
$6.4M
|
|
| 01/23/2017 |
4
| Mirabelli Christopher (CEO,Pres,Chairman of the Board) has filed a Form 4 on LEAP THERAPEUTICS, INC. |
| 01/23/2017 |
3
| Mirabelli Christopher (CEO,Pres,Chairman of the Board) has filed a Form 3 on LEAP THERAPEUTICS, INC. |
| 02/19/2016 |
4
| HEALTHCARE VENTURES VII LP (Former 10% Owner) has filed a Form 4 on GLOBEIMMUNE INC|
Txns:
| Sold 5,000 shares
@ $1.53, valued at
$7.7k
Sold 5,000 shares
@ $1.4, valued at
$7k
Sold 5,000 shares
@ $1.39, valued at
$7k
|
|
| 02/17/2016 |
4
| Mirabelli Christopher (10% Owner) has filed a Form 4 on PROTEOSTASIS THERAPEUTICS, INC.|
Txns:
| Converted 1,774,295 shares
@ $0
Bought 375,000 shares
@ $8, valued at
$3M
Converted 11,600,000 options to buy
@ $0
Converted 2,319,750 options to buy
@ $0
Disposed of 160,000 options to buy
@ $1, valued at
$160k
Acquired 14,800 warrants
@ $10.8102, valued at
$160k
|
|
| 02/16/2016 |
4
| HEALTHCARE VENTURES VII LP (10% Owner) has filed a Form 4 on GLOBEIMMUNE INC|
Txns:
| Sold 5,000 shares
@ $1.72, valued at
$8.6k
Sold 5,000 shares
@ $1.59, valued at
$8k
Sold 5,000 shares
@ $1.51, valued at
$7.6k
|
|
| 02/12/2016 |
4
| Mirabelli Christopher (10% Owner) has filed a Form 4 on PROTEOSTASIS THERAPEUTICS, INC.|
Txns:
| Granted 45,760 options to buy
@ $8, valued at
$366.1k
|
|
| 02/10/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 07/08/2014 |
4
| HEALTHCARE VENTURES VII LP (10% Owner) has filed a Form 4 on GLOBEIMMUNE INC|
Txns:
| Converted 80,533 shares
@ $0
Converted 188,096 shares
@ $0
Converted 123,574 shares
@ $0
Converted 2,064 shares
@ $0
Bought 190,000 shares
@ $10, valued at
$1.9M
Converted 2,528,000 convertible preferred
@ $0
Converted 5,904,335 convertible preferred
@ $0
Converted 3,879,015 convertible preferred
@ $0
Converted 64,809 convertible preferred
@ $0 |
|
| 02/07/2014 |
4
| HealthCare Ventures VIII, L.P. (10% Owner) has filed a Form 4 on TREVENA INC|
Txns:
| Converted 967,741 shares
@ $0
Converted 677,419 shares
@ $0
Converted 504,033 shares
@ $0
Bought 297,058 shares
@ $7, valued at
$2.1M
Converted 6,000,000 preferred shares
@ $0
Converted 4,200,000 preferred shares
@ $0
Converted 3,125,000 preferred shares
@ $0 |
|
| 12/17/2013 |
4
| HEALTHCARE VENTURES VII LP (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Converted 653,594 shares
@ $0
Converted 438,453 shares
@ $0
Converted 506,086 shares
@ $0
Converted 7,335 shares
@ $6.4022, valued at
$47k
Converted 267,535 shares
@ $7, valued at
$1.9M
Bought 713,463 shares
@ $7, valued at
$5M
Converted 5,000,000 preferred shares
@ $0
Converted 7,453,704 preferred shares
@ $0
Converted 8,603,477 preferred shares
@ $0
Converted options to buy
@ $0
Converted notes
@ $0 |
|
| 12/23/2011 |
4
| HEALTHCARE VENTURES VII LP (10% Owner) has filed a Form 4 on Radius Health, Inc.|
Txns:
| Bought 19,651 preferred shares
@ $81.42, valued at
$1.6M
Bought 19,651 preferred shares
@ $81.42, valued at
$1.6M
|
|
| 05/24/2011 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/05/2010 |
4
| HEALTHCARE VENTURES VII LP (10% Owner) has filed a Form 4 on PHARMATHENE, INC|
Txns:
| Converted 935,814 shares
@ $2.5417, valued at
$2.4M
Converted 935,814 options to buy
@ $2.5417, valued at
$2.4M
|
|
| 10/07/2009 |
4
| HealthCare Ventures VIII, L.P. (10% Owner) has filed a Form 4 on THRESHOLD PHARMACEUTICALS INC|
Txns:
| Bought 1,570,680 shares
@ $0
Bought 628,272 warrants
@ $2.23, valued at
$1.4M
Acquired 588,235 warrants
@ $1.86, valued at
$1.1M
|
|
| 07/30/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|